• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精性肝病患者丙型肝炎病毒感染的流行率:队列研究和系统评价。

Prevalence of hepatitis C virus infection in alcoholic patients: cohort study and systematic review.

机构信息

Alcoholism Unit, Department of Internal Medicine, University Hospital of Salamanca, P° San Vicente, 58-156, Salamanca 37007, Spain.

出版信息

Alcohol Alcohol. 2013 Sep-Oct;48(5):564-9. doi: 10.1093/alcalc/agt044. Epub 2013 May 19.

DOI:10.1093/alcalc/agt044
PMID:23690232
Abstract

AIMS

Prevalence of chronic hepatitis C virus (HCV) infection among alcoholics is thought to be higher than in the general population, although prevalence rates reported are quite variable. Our study is aimed to analyze HCV prevalence in a cohort of alcoholics and to perform a systematic review on this topic.

PATIENTS AND METHODS

A total of 396 alcoholic patients consecutively referred to our Alcoholism Unit were included. HCV infection status and other clinical variables were recorded for each patient. Variables associated with HCV infection were analyzed by means of logistic regression. Additionally, we performed a systematic review focused on previous studies on this topic.

RESULTS

Among our alcoholic patients, 14 of them (3.53%) had chronic HCV infection. Variables independently associated with HCV infection were female gender, injection drug use (IDU) and the presence of alcoholic liver disease (ALD). Twenty-four studies analyzing HCV prevalence in alcoholic patients were included in our systematic review, showing prevalence rates of HCV infection ranging from 2.1 to 51% and an average weighted prevalence of 16.32%.

CONCLUSION

In our series, the prevalence rate of chronic HCV infection among alcoholic patients is lower than previously reported, which is probably explained by the relatively low number of patients with ALD or IDU in our sample. Prevalence rates previously published are quite different and the presence of ALD and/or IDU can act as confounding factors for HCV prevalence among alcoholics.

摘要

目的

酗酒者中慢性丙型肝炎病毒 (HCV) 感染的患病率被认为高于普通人群,尽管报告的患病率差异很大。我们的研究旨在分析一组酗酒者中 HCV 的流行情况,并对此主题进行系统评价。

患者和方法

共纳入 396 名连续转至我们酒精中毒科的酗酒者。为每位患者记录 HCV 感染状况和其他临床变量。通过逻辑回归分析与 HCV 感染相关的变量。此外,我们进行了一项系统评价,重点关注该主题的先前研究。

结果

在我们的酗酒者中,有 14 人(3.53%)患有慢性 HCV 感染。与 HCV 感染独立相关的变量是女性、注射吸毒 (IDU) 和酒精性肝病 (ALD) 的存在。我们的系统评价纳入了 24 项分析酗酒者 HCV 流行情况的研究,显示 HCV 感染的患病率范围为 2.1%至 51%,加权平均患病率为 16.32%。

结论

在我们的系列中,酗酒者中慢性 HCV 感染的患病率低于先前报告的水平,这可能是由于我们样本中 ALD 或 IDU 患者数量相对较少所致。先前发表的患病率差异很大,ALD 和/或 IDU 的存在可能是酗酒者中 HCV 患病率的混杂因素。

相似文献

1
Prevalence of hepatitis C virus infection in alcoholic patients: cohort study and systematic review.酒精性肝病患者丙型肝炎病毒感染的流行率:队列研究和系统评价。
Alcohol Alcohol. 2013 Sep-Oct;48(5):564-9. doi: 10.1093/alcalc/agt044. Epub 2013 May 19.
2
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
3
Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.急性丙型肝炎感染的药物干预:一项网状Meta分析尝试
Cochrane Database Syst Rev. 2017 Mar 13;3(3):CD011644. doi: 10.1002/14651858.CD011644.pub2.
4
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.
5
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
6
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
7
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.全球注射吸毒流行状况以及注射吸毒者的社会人口学特征和艾滋病毒、乙肝病毒及丙肝病毒流行状况:多阶段系统评价。
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. doi: 10.1016/S2214-109X(17)30375-3. Epub 2017 Oct 23.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
A New Measure of Quantified Social Health Is Associated With Levels of Discomfort, Capability, and Mental and General Health Among Patients Seeking Musculoskeletal Specialty Care.一种新的量化社会健康指标与寻求肌肉骨骼专科护理的患者的不适程度、能力以及心理和总体健康水平相关。
Clin Orthop Relat Res. 2025 Apr 1;483(4):647-663. doi: 10.1097/CORR.0000000000003394. Epub 2025 Feb 5.
10
Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.聚乙二醇干扰素 α 和利巴韦林治疗适合缩短疗程、再治疗或合并 HCV/HIV 感染的慢性丙型肝炎患者:系统评价和经济评估。
Health Technol Assess. 2011 Apr;15(17):i-xii, 1-210. doi: 10.3310/hta15170.

引用本文的文献

1
Alcohol Use Disorder Pharmacotherapy in Patients With Alcohol-Related Liver Disease: A Scoping Review.酒精相关肝病患者的酒精使用障碍药物治疗:一项范围综述
Can J Gastroenterol Hepatol. 2025 Apr 3;2025:6455092. doi: 10.1155/cjgh/6455092. eCollection 2025.
2
Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies.酒精使用在 HIV/丙型肝炎病毒合并感染中的作用对全因和病因特异性死亡率的影响:队列研究的合作。
J Viral Hepat. 2023 Sep;30(9):775-786. doi: 10.1111/jvh.13863. Epub 2023 Jun 20.
3
Prevalence of HIV in mental health service users: a retrospective cohort study.
精神卫生服务使用者中的艾滋病毒流行情况:一项回顾性队列研究。
BMJ Open. 2023 Apr 25;13(4):e067337. doi: 10.1136/bmjopen-2022-067337.
4
Effects of alcohol consumption on viral hepatitis B and C.饮酒对乙型和丙型病毒性肝炎的影响。
World J Clin Cases. 2021 Nov 26;9(33):10052-10063. doi: 10.12998/wjcc.v9.i33.10052.
5
Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use.评估慢性丙型肝炎合并不健康饮酒患者的肝脏疾病。
World J Gastroenterol. 2021 Jun 21;27(23):3223-3237. doi: 10.3748/wjg.v27.i23.3223.
6
Neuroimaging and Cognitive Evidence for Combined HIV-Alcohol Effects on the Central Nervous System: A Review.神经影像学和认知证据表明,HIV 和酒精对中枢神经系统有联合影响:综述。
Alcohol Clin Exp Res. 2021 Feb;45(2):290-306. doi: 10.1111/acer.14530. Epub 2020 Dec 30.
7
Alcohol and hepatocellular carcinoma.酒精与肝细胞癌
BMJ Open Gastroenterol. 2019 Apr 3;6(1):e000260. doi: 10.1136/bmjgast-2018-000260. eCollection 2019.
8
Evaluation of hepatitis A, B, and C serology in patients with cirrhosis and intensive alcohol consumption.对肝硬化且大量饮酒患者的甲型、乙型和丙型肝炎血清学评估。
North Clin Istanb. 2018 May 22;5(2):109-113. doi: 10.14744/nci.2018.50570. eCollection 2018.
9
Hepatitis C infection substantially reduces survival of alcohol-dependent patients.丙型肝炎感染显著降低了酒精依赖患者的生存率。
Clin Epidemiol. 2018 Aug 1;10:897-905. doi: 10.2147/CLEP.S162308. eCollection 2018.
10
S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder.血液中S100B和炎性细胞因子水平作为丙型肝炎病毒合并感染和酒精使用障碍中血脑屏障损伤及精神障碍潜在标志物的研究
Alcohol Clin Exp Res. 2018 Jun 28. doi: 10.1111/acer.13796.